Investigation of the Effects of Pilates Exercises on Menopause Symptoms and Sexual Dysfunction in Postmenopausal Women

What this trial studies

Menopause represents a major transition in a woman's life as estrogen and progesterone levels decline, and this hormonal shift is associated with a range of symptoms that can significantly impact a woman's quality of life, including vasomotor symptoms such as hot flushes and night sweats, and urogenital symptoms such as vaginal dryness and sexual dysfunction.

Conditions in scope

• Menopausal Syndrome
• Sexual Dysfunctions
• Quality of Life and Menopause

Interventions

• PİLATES GROUP (Other) — A total of 16 sessions were applied for 8 weeks, 2 sessions per week.
• Behavioral: lifestyle changes (Other) — presentation including lifestyle changes was prepared and training was provided.

Who can join

Women only · Ages 45 Years to 60 Years · Accepts healthy volunteers.

Inclusion criteria

• Women who have reached menopause
• Being physically or cognitively competent to exercise
• Those who agreed to participate in the study

Exclusion criteria

• Those with serious heart disease, DM, kidney, liver, thyroid disease and cancer patients
• Those receiving hormone therapy
• People using antipsychotic medication
• Those using steroids and derivative drugs
• People using insulin sensitizing drugs Those with musculoskeletal system diseases that would prevent them from exercising Cognitive problems that affect cooperation

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

Status & timeline

• Overall status: Completed
• Study type: Interventional
• Phase: N/A
• Start date: 2023-09-15
• Primary completion: 2024-03-05
• Last update posted: 2025-02-20
• First posted: 2025-02-20

Sponsor & contact

Lead sponsor: Batman University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

• Menopause Rating Scale (MRS) (8 week)
  This scale was used to assess the severity of menopausal symptoms experienced by the participants. The MRS covers a range of symptoms, including vasomotor, psychological, and urogenital symptoms. Participants rated the severity of each symptom on a Likert scale, with higher scores indicating more severe symptoms. The total score of the scale is calculated with the scores obtained from each…
• Menopausal-Specific Quality of Life Scale (MENQOL) (8 week)
  This scale measures the impact of menopausal symptoms on quality of life across several domains, including physical, psychological, and sexual well-being. The MENQOL provides a comprehensive assessment of how menopausal symptoms affect daily life, with higher scores indicating a greater negative impact.MENQOL is a Likert-type scale containing 32 questions. It consists of four sub-areas: vasomotor, psychosocial, physical and sexual. Each…
• Female Sexual Function Index (FSFI) (8 week)
  The FSFI was used to evaluate sexual function, focusing on domains such as sexual desire, arousal, lubrication, orgasm, satisfaction, and pain. Participants were asked to rate their experiences in each domain over the past 4 weeks. Higher FSFI scores indicate better sexual function.The highest raw score that can be obtained from the survey is 95, and the lowest is 4.…

Related ClearedRx care

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.